Pharmacotherapy of anorexia nervosa and bulimia.
D000639:Amitriptyline / Q000627:therapeutic use; D000856:Anorexia Nervosa / Q000188:drug therapy*; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D002997:Clomipramine / Q000627:therapeutic use; D003533:Cyproheptadine / Q000627:therapeutic use; D004311:Double-Blind Method; D005247:Feeding Behavior / Q000187:drug effects; D001068:Feeding and Eating Disorders / Q000188:drug therapy*; D006801:Humans; D006963:Hyperphagia / Q000188:drug therapy*; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000627:therapeutic use*
D000929:Antidepressive Agents, Tricyclic; D008996:Monoamine Oxidase Inhibitors; D011619:Psychotropic Drugs; D000639:Amitriptyline; D003533:Cyproheptadine; D010672:Phenytoin; D002997:Clomipramine; D002746:Chlorpromazine